|1.||Tarkowski, Radoslaw: 1 article (12/2012)|
|2.||Wojnar, Andrzej: 1 article (12/2012)|
|3.||Bebenek, Marek: 1 article (12/2012)|
|4.||Dziegiel, Piotr: 1 article (12/2012)|
|5.||Halon, Agnieszka: 1 article (12/2012)|
|6.||Gomulkiewicz, Agnieszka: 1 article (12/2012)|
|7.||Fortuna, Krzysztof: 1 article (12/2012)|
|8.||Kornafel, Jan: 1 article (12/2012)|
|9.||Matkowski, Rafal: 1 article (12/2012)|
|10.||Szelachowska, Jolanta: 1 article (12/2012)|
|1.||Breast Neoplasms (Breast Cancer)
10/15/1993 - "In breast cancer, in particular, the mean increase for prothymosin alpha and parathymosin alpha was 17.9- and 11.5-fold, respectively. "
03/10/1994 - "It was also possible to reveal significantly higher levels of both alpha-thymosins in breast cancer tissue compared to the nearby healthy tissue--the mean of 14 samples was over 14-fold higher--suggesting a role of both prothymosin alpha and parathymosin alpha in cell proliferation. "
05/01/1998 - "In the present study, we investigated the clinical significance of the levels of alpha-thymosins in relation to established prognostic factors, both in breast cancer and non-malignant breast lesions, alpha-thymosin levels were measured in breast tissue extracts by specific radioimmunoassays (RIAs) developed for human prothymosin alpha (ProT alpha) and parathymosin alpha (ParaT alpha) and were found to be significantly higher (up to 17.2-fold) in malignant but not in benign breast lesions, as compared to the values of the neighbouring tissues. "
|2.||Thyroid Neoplasms (Thyroid Cancer)
|3.||Rectal Neoplasms (Rectal Cancer)
12/01/2012 - "Material for the study originated from 21 patients with rectal cancer at stage II or III. Material for immunohistochemical studies [MTI/II, Minichromosome Maintenance Protein 3 (MCM3), Ki-67] and real-time polymerase chain reaction (PCR) (mRNA of MT1F, MT1X and MT2A) was sampled twice: during rectoscopic examination before the start of the preoperative radiotherapy (samples A) and from the post operative specimen, following radiotherapy (samples B). "
|4.||Opportunistic Infections (Opportunistic Infection)
02/01/1985 - "The common sequences do not include residues 2-9, which accounts for the poor reactivity of parathymosin alpha with an antibody directed against this epitope in thymosin alpha 1. Parathymosin alpha appears to modulate the action of prothymosin alpha in protecting sensitive strains of mice against opportunistic infection with Candida albicans."
|3.||Messenger RNA (mRNA)
|6.||Carrier Proteins (Binding Protein)